Cannabtimes
<![CDATA[PHOENIX, November 10, 2020 — PRESS RELEASE — TILT Holdings Inc., a provider of business solutions to the global cannabis industry, has announced an expansion of the partnership between its wholly-owned inhalation technology subsidiary, Jupiter Research, LLC, and Israeli-based Kanabo Research Ltd., a researcher and developer of cannabis and CBD-derived medical cannabis solutions and inhalation devices. Jupiter and Kanabo previously collaborated to obtain medical device registration for Jupiter’s flagship product, the Liquid9 (L-9), currently approved for use in hospitals and clinical trials in Israel. The L-9 is undergoing rigorous testing for safety, accuracy and durability so that new generations of the device are able to meet the requirements to obtain a CE marking for a medically certified inhalation device. Under the terms of the expanded partnership, the two parties will seek to develop a new, medically certified inhalation device specifically designed to meet the directives outlined in the European Union (EU) Medical Devices Regulation (MDR) in 2021. Kanabo will become the exclusive distributor of the medical platform in the EU and work closely with medical cannabis pharmacies to bring the platform to millions of patients. “The European cannabis and CBD marketplace is well-positioned for significant growth over the next five…
Excerpt only …
READ MORE BELOW
Source : TILT Holdings Announces Expanded Partnership with Israel’s Kanabo Research to Develop a New, Medically Certified Inhalation Device
reposted by Cannabis News World